Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Article
  • Published:

Regulated, electroporation-mediated delivery of pro-opiomelanocortin gene suppresses chronic constriction injury-induced neuropathic pain in rats

Abstract

We previously reported that intrathecal pro-opiomelanocortin gene electroporation could reduce pain sensitivity induced by chronic constriction injury (CCI) of the sciatic nerve. For optimal use of antinociceptive gene therapy, it might be important to control the expression of the transfected gene extrinsically. For this purpose, a doxycycline-controlled transrepressor system composed of two plasmids coding, respectively, for pro-opiomelanocortin gene (pTRE2-POMC) and the silencer (pTel-off) was employed. The regulation of beta-endorphin expression was first assessed in spinal neuronal culture, then we electrotranfected this plasmid into the spinal cord of mononeuropathic rats and evaluated the analgesic potential of this therapy in vivo by thermal and mechanical withdrawal latency. Intraperitoneal injections of various doses of doxycycline were made to elucidate the possible exogenous downregulation of transfected beta-endorphin gene expression in vivo. The levels of beta-endorphin were analyzed by intrathecal microdialysis and radioimmunoassay. Intrathecal pTRE2-POMC/pTel-off electroporation elevated spinal beta-endorphin levels, as manifested in a significantly elevated pain threshold for chronic constriction injury limbs. Intraperitoneal doxycycline decreased the antinociceptive effect and spinal beta-endorphin levels in a dose-dependent manner. We concluded that intrathecal pTRE2-POMC/pTel-off electroporation alleviates CCI-induced limb pain, and can be controlled by intraperitoneal doxycycline administration.

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  1. Oyama T et al. Profound analgesic effects of beta-endorphin in man. Lancet 1980; 1: 122–124.

    Article  CAS  Google Scholar 

  2. Wen HL et al. Intrathecal administration of beta-endorphin and dynorphin-(1-13) for the treatment of intractable pain. Life Sci 1985; 37: 1213–1220.

    Article  CAS  Google Scholar 

  3. Yaksh TL, Henry JL . Antinociceptive effects of intrathecally administered human beta-endorphin in the rat and cat. Can J Physiol Pharmacol 1978; 56: 754–759.

    Article  CAS  Google Scholar 

  4. Yaksh TL, Gross KE, Li CC . Studies on the intrathecal effect of beta-endorphin in primate. Brain Res 1982; 241: 261–269.

    Article  CAS  Google Scholar 

  5. Mack KJ, Killian A, Weyhenmeyer JA . Comparison of mu, delta, and kappa opiate binding sites in rat brain and spinal cord. Life Sci 1984; 34: 281–285.

    Article  CAS  Google Scholar 

  6. Atweh SF, Kuhar MJ . Autoradiographic localization of opiatereceptors in rat brain. I. Spinal and lower medulla. Brain Res 1977; 124: 53–67.

    Article  CAS  Google Scholar 

  7. Morris BJ, Herz A . Distinct distribution of opioid receptor typesin rat lumbar spinal cord. Naunyn-Schmiedebergs Arch Pharmacol 1987; 336: 240–243.

    Article  CAS  Google Scholar 

  8. Kitahata LM, Collins JG . Spinal action of narcotic analgesics. Anesthesiology 1981; 54: 153–163.

    Article  CAS  Google Scholar 

  9. Aimone LD, Yaksh TL . Opioid modulation of capsaicin-evoked release of substance P from rat spinal cord in vivo. Peptides 1989; 10: 1127–1131.

    Article  CAS  Google Scholar 

  10. Go VL, Yaksh TL . Release of substance P from the cat spinal cord. J Physiol 1987; 391: 141–167.

    Article  CAS  Google Scholar 

  11. Seybold VS, Elde RP . Receptor autoradiography in thoracic spinal cord: correlation of neurotransmitter binding sites with sympathoadrenal neurons. J Neurosci 1984; 4: 2533–2542.

    Article  CAS  Google Scholar 

  12. Brazenor GA . Long term intrathecal administration of morphine: a comparison of bolus infection via reservoir with continuous infusion by implanted pump. Neurosurgery 1987; 21: 484–491.

    Article  CAS  Google Scholar 

  13. Oyama T, Murakawa T, Baba S, Nagao H . Continuous vs bolus epidural morphine. Acta Anaesthesiol Scand (Suppl) 1987; 85: 77–79.

    Article  CAS  Google Scholar 

  14. Penn RD, Paice JA . Chronic intrathecal morphine for intractable pain. J Neurosurg 1987; 67: 182–186.

    Article  CAS  Google Scholar 

  15. Richelson E . Spinal opiate administration for chronic pain: a major advance in therapy. Mayo Clin Proc 1981; 56: 523.

    CAS  PubMed  Google Scholar 

  16. Hassenbusch SJ et al. Constant infusion of morphine for intractable cancer pain using an implanted pump. J Neurosurg 1990; 73: 405–409.

    Article  CAS  Google Scholar 

  17. Lin CR et al. Electroporation-mediated pain-killer gene therapy for mononeuropathic rats. Gene Therapy 2002; 18: 1247–1253.

    Article  Google Scholar 

  18. Finegold AA, Mannes AJ, Iadarola MJ . A paracrine paradigm for in vivo gene therapy in the central nervous system: treatment of chronic pain. Hum Gene Ther 1999; 10: 1251–1257.

    Article  CAS  Google Scholar 

  19. Lin CR et al. Electroporation for direct spinal gene transfer in rats. Neurosci Lett 2002; 317: 1–4.

    Article  CAS  Google Scholar 

  20. Rubanyi GM . The future of human gene therapy. Mol Aspects Med 2001; 22: 113–142.

    Article  CAS  Google Scholar 

  21. Weber W, Fussenegger M . Artificial mammalian gene regulation networks-novel approaches for gene therapy and bioengineering. J Biotechnol 2002; 98: 161–187.

    Article  CAS  Google Scholar 

  22. Clackson T . Regulated gene expression systems. Gene Therapy 2000; 7: 120–125.

    Article  CAS  Google Scholar 

  23. Baron U, Bujard H . Tet repressor-based system for regulated gene expression in eukaryotic cells: principles and advances. Methods Enzymol 2000; 327: 401–421.

    Article  CAS  Google Scholar 

  24. Gossen M, Bujard H . Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 1992; 89: 5547–5551.

    Article  CAS  Google Scholar 

  25. Gossen M et al. Transcriptional activation by tetracyclines in mammalian cells. Science 1995; 268: 1766–1769.

    Article  CAS  Google Scholar 

  26. Bohl D, Salvetti A, Moullier P, Heard JM . Control of erythropoietin delivery by doxycycline in mice after intramuscular injection of adeno-associated vector. Blood 1998; 92: 1512–1517.

    CAS  Google Scholar 

  27. Saitoh Y et al. Analgesia induced by transplantation of encapsulated tumor cells secreting beta-endorphin. J Neurosurg 1995; 82: 630–634.

    Article  CAS  Google Scholar 

  28. Saitoh Y et al. Dose-dependent doxycycline-mediated adrenocorticotropic hormone secretion from encapsulated Tet-on proopiomelanocortin Neuro2A cells in the subarachnoid space. Hum Gene Ther 1998; 9: 997–1002.

    Article  CAS  Google Scholar 

  29. Ishii K, Isono M, Inoue R, Hori S . Attempted gene therapy for intractable pain: dexamethasone-mediated exogenous control of beta-endorphin secretion in genetically modified cells and intrathecal transplantation. Exp Neurol 2000; 166: 90–98.

    Article  CAS  Google Scholar 

  30. Gehl J, Mir LM . Determination of optimal parameters for in vivo gene transfer by electroporation, using a rapid in vivo test for cell permeabilization. Biochem Biophys Res Commun 1999; 261: 377–380.

    Article  CAS  Google Scholar 

  31. Lan CY et al. Immunoneutralization of c-Fos using intrathecal antibody electroporation attenuates chronic constrictive injury-induced hyperalgesia and regulates preprodynorphin expression in rats. Anesthesiology 2003; 99: 938–946.

    Article  Google Scholar 

  32. Teichler Zallen D . US gene therapy in crisis. Trends Genet 2000; 16: 272–275.

    Article  CAS  Google Scholar 

  33. Osumi N, Inoue T . Gene transfer into cultured mammalian embryos by electroporation. Methods 2001; 24: 35–42.

    Article  CAS  Google Scholar 

  34. Maruyama H et al. Skin-targeted gene transfer using in vivo electroporation. Gene Therapy 2001; 23: 1808–1812.

    Article  Google Scholar 

  35. Lin CR et al. Intrathecal spinal progenitor cell transplantation for the treatment of neuropathic pain. Cell Transplant 2002; 11: 17–24.

    Article  CAS  Google Scholar 

  36. Lin CR et al. Antinociceptive potentiation and attenuation of tolerance by intrathecal electric stimulation in rats. Anesth Analg 2003; 96: 1711–1716.

    Article  Google Scholar 

  37. Hargreaves K et al. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 1988; 32: 77–88.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by Grant No. 92-2314-B-182A-149- to Chung-Ren Lin from the National Science Council, Taipei, Taiwan.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wu, CM., Lin, MW., Cheng, JT. et al. Regulated, electroporation-mediated delivery of pro-opiomelanocortin gene suppresses chronic constriction injury-induced neuropathic pain in rats. Gene Ther 11, 933–940 (2004). https://doi.org/10.1038/sj.gt.3302244

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/sj.gt.3302244

Keywords

This article is cited by

Search

Quick links